Grupo de Investigación en cáncer de próstata
GICAP-CUN
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario Central de Asturias (5)
2020
-
Current role of 18F-FDG-PET in the differential diagnosis of the main forms of dementia
Clinical and Translational Imaging, Vol. 8, Núm. 3, pp. 127-140
2018
-
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies
BJU International, Vol. 122, Núm. 6, pp. 1049-1065
-
Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice
Actas Urologicas Espanolas, Vol. 42, Núm. 4, pp. 238-248
2017
-
Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study – GESCAP group
Actas Urologicas Espanolas, Vol. 41, Núm. 6, pp. 359-367
2016
-
Tendencias de tratamiento en el cáncer de próstata clínicamente localizado. Análisis poblacional a nivel nacional: grupo GESCAP
Actas Urologicas Espanolas, Vol. 40, Núm. 4, pp. 209-216